<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
                xmlns:wfw="http://wellformedweb.org/CommentAPI/"
                xmlns:dc="http://purl.org/dc/elements/1.1/"
                xmlns:sy="http://purl.org/rss/1.0/modules/syndication/">
<channel>
<title>Ambry Genetics News by Category: Genetic Testing</title>
<link>https://blog.ambrygen.com/list/category/Genetic%20Testing</link>
<description>Find the latest Ambry Genetics news by category: Genetic Testing</description>
<language>en</language>
<image>
<title>Ambry Genetics Blog</title>
<link>https://blog.ambrygen.com/list/category/Genetic%20Testing</link>
<url>https://blog.ambrygen.com/assets/img/logo/Ambry_logo_web.jpg</url>
</image>
<item>
<title>Hereditary Cancer Testing Menu Enhancements–May 2026</title>
<link>https://blog.ambrygen.com/ambry/post/443/hereditary-cancer-testing-menu-enhancements-may-2026</link>
<description>Describing the new hereditary cancer test menu changes</description>
<pubDate>Tue, 19 May 26 06:44:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: RYR2</title>
<link>https://blog.ambrygen.com/ambry/post/445/the-gene-scene-ryr2</link>
<description>Haley Streff, MS, CGC, explores ventricular arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT) and calcium release deficiency syndrome (CRDS), associated with variants in the RYR2 gene.</description>
<pubDate>Tue, 19 May 26 06:11:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>DuoNovo: How Long-Read Sequencing Can Improve Access to Genetic Testing</title>
<link>https://blog.ambrygen.com/ambry/post/444/duonovo-how-long-read-sequencing-can-improve-access-to-genetic-testing</link>
<description>De novo variants cause many rare genetic disorders. duoNovo uses long-read sequencing to identify de novo variants using only one biological parent, improving access to the most accurate testing for more patients.</description>
<pubDate>Wed, 13 May 26 06:26:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: SDHB</title>
<link>https://blog.ambrygen.com/ambry/post/441/the-gene-scene-sdhb</link>
<description>In this Gene Scene, Jewel Wasson, MS, CGC, explores the SDHB gene and its association with SDHB-related Hereditary Pheochromocytoma-Paraganglioma and SDHB-related Mitochondrial Complex II Deficiency.</description>
<pubDate>Tue, 12 May 26 07:41:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: MYBPC3</title>
<link>https://blog.ambrygen.com/ambry/post/440/the-gene-scene-mybpc3</link>
<description>Connolly Steigerwald explores the MYBP3 gene. Pathogenic variants in this gene have been associated with a spectrum of MYBPC3-related cardiomyopathies, including hypertrophic cardiomyopathy (HCM) and left ventricular noncompaction cardiomyopathy (LVNC),</description>
<pubDate>Tue, 05 May 26 05:31:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: RYR1</title>
<link>https://blog.ambrygen.com/ambry/post/442/the-gene-scene-ryr1</link>
<description>Each week, we explore a gene from the ACMG Secondary Findings list. Learn about the RYR1 gene and related pathogenic variants</description>
<pubDate>Tue, 28 Apr 26 09:22:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>Empowered Patients Start with Better Education</title>
<link>https://blog.ambrygen.com/ambry/post/439/empowered-patients-start-with-better-education</link>
<description>The Ambry CARE Program® (CARE) believes patients make better decisions when they understand their options. That’s why education is built directly into the CARE experience, designed around how patients actually learn.</description>
<pubDate>Mon, 27 Apr 26 06:38:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: TMEM127</title>
<link>https://blog.ambrygen.com/ambry/post/438/the-gene-scene-tmem127</link>
<description>Sarah Campian, MS, CGC, explores the TMEM127 gene and TMEM127-related hereditary pheochromocytoma-paraganglioma (PCC-PGL) in this Gene Scene covering a clinically actionable gene from the ACMG Secondary Findings List</description>
<pubDate>Tue, 21 Apr 26 06:32:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>Leading the Shift to Proactive Care: The Christ Hospital’s High‑Risk Program Strategy</title>
<link>https://blog.ambrygen.com/ambry/post/435/leading-the-shift-to-proactive-care-the-christ-hospitals-high-risk-program-strategy</link>
<description>The Christ Hospital Health Network is turning to proactive population health strategy with The CARE Program to identify more at-risk patients for hereditary cancer risks.</description>
<pubDate>Thu, 16 Apr 26 06:45:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: HPDL</title>
<link>https://blog.ambrygen.com/ambry/post/437/the-gene-scene-hpdl</link>
<description>Charlie King, MS, CGC, explores the HPDL gene and associations with related neurological disorders. Emerging treatments have impacted some patients diagnosed with an HPDL-related neurological disorder.</description>
<pubDate>Tue, 14 Apr 26 06:46:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>A Hidden Cancer, Found in Time: One Patient’s CARE Journey</title>
<link>https://blog.ambrygen.com/ambry/post/436/a-hidden-cancer-found-in-time-one-patients-care-journey</link>
<description>Danielle Rogers discusses the case study of a patient with RET, her genetic testing, and personalized screening journey.</description>
<pubDate>Thu, 09 Apr 26 08:12:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: GAA</title>
<link>https://blog.ambrygen.com/ambry/post/434/the-gene-scene-gaa</link>
<description>Explore the clinical implications of variants of the GAA gene, which are known to cause glycogen storage disease type II, commonly known as Pompe disease, which is inherited in an autosomal recessive fashion.</description>
<pubDate>Tue, 07 Apr 26 06:24:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: SMAD4</title>
<link>https://blog.ambrygen.com/ambry/post/432/the-gene-scene-smad4</link>
<description>Rachel Bluebond explores SMAD4 and its associated conditions of  juvenile polyposis syndrome (JPS) and Myhre syndrome.</description>
<pubDate>Tue, 24 Mar 26 06:15:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: CASQ2</title>
<link>https://blog.ambrygen.com/ambry/post/430/the-gene-scene-casq2</link>
<description>The Gene Scene covers CASQ2 from the ACMG Secondary Findings list and it's link to CASQ2-related catecholaminergic polymorphic ventricular tachycardia (CPVT).</description>
<pubDate>Tue, 17 Mar 26 06:37:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>Making Waves with MAVES</title>
<link>https://blog.ambrygen.com/ambry/post/424/making-waves-with-maves</link>
<description>Discover how a BRCA2 variant reclassification, thanks in part to new MAVEs data and the Ambry Classifi® Program, unlocked potentially life-saving options for a 2x breast cancer survivor.</description>
<pubDate>Wed, 11 Mar 26 07:48:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: CALM2</title>
<link>https://blog.ambrygen.com/ambry/post/428/the-gene-scene-calm2</link>
<description>In this Gene Scene, Katherine Crawford covers gene-disase validity in the CALM2 gene leading CALM2–related calmodulinopathy with clinical considerations for genetic counselors.</description>
<pubDate>Tue, 10 Mar 26 06:19:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: RB1</title>
<link>https://blog.ambrygen.com/ambry/post/427/the-gene-scene-rb1</link>
<description>Caitlin Reid, MS, LGC, explores RB1 and its association with RBI-related retinoblastoma in this weekly snapshot of clinically actionable genes from the ACMG Secondary Findings List</description>
<pubDate>Tue, 03 Mar 26 06:53:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: RPE65</title>
<link>https://blog.ambrygen.com/ambry/post/423/the-gene-scene-rpe65</link>
<description>Brooke Sample, MS, CGC, covers he RPE65 gene, which is critical for the &quot;visual cycle&quot;—the process of regenerating light-sensitive pigments in the eye. Mutations in this gene cause RPE65-related retinopathies which vary in severity and age of onset.</description>
<pubDate>Tue, 17 Feb 26 06:00:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: LMNA</title>
<link>https://blog.ambrygen.com/ambry/post/422/the-gene-scene-lmna</link>
<description>This Gene Scene covers pathogenic variants in LMNA, which are associated with more than 10 distinct disorders with high clinical variability, referred to as the laminopathies.</description>
<pubDate>Tue, 10 Feb 26 07:14:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: BMPR1A</title>
<link>https://blog.ambrygen.com/ambry/post/421/the-gene-scene-bmpr1a</link>
<description>Caitlin Reid, MS, LGC, explores the BMPR1A gene and its connection to juvenile polyposis syndrome (JPS).</description>
<pubDate>Tue, 03 Feb 26 07:58:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: KCNH2</title>
<link>https://blog.ambrygen.com/ambry/post/420/the-gene-scene-kcnh2</link>
<description>This Gene Scene covers pathogenic variants in KCNH2, known to cause KCNH2-related long QT syndrome and KCNH2-related short QT syndrome</description>
<pubDate>Tue, 27 Jan 26 08:31:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: APOB</title>
<link>https://blog.ambrygen.com/ambry/post/418/the-gene-scene-apob</link>
<description>In this Gene Scene, Haley Streff, MS, CGC, covers the APOB gene and its association with familial hypercholesterolemia.</description>
<pubDate>Tue, 20 Jan 26 07:44:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: MAX</title>
<link>https://blog.ambrygen.com/ambry/post/419/the-gene-scene-max</link>
<description>Jessica Scott, MS, CGC, joins us in the Gene Scene to discuss MAX-related hereditary paraganglioma-pheochromocytoma and MAX-related multiple congenital anomalies syndrome.</description>
<pubDate>Tue, 13 Jan 26 08:14:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>The Gene Scene: RUNX1</title>
<link>https://blog.ambrygen.com/ambry/post/417/the-gene-scene-runx1</link>
<description>Frankie Fann explores RUNX1 and its association with Familial Platelet Disorder with Associated Myeloid Malignancies in this Gene Scene.</description>
<pubDate>Tue, 06 Jan 26 06:22:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
<item>
<title>Study Finds One in Four People With Sarcoma Carry a Pathogenic Variant: Why Germline Testing Matters</title>
<link>https://blog.ambrygen.com/ambry/post/414/study-finds-one-in-four-people-with-sarcoma-carry-a-pathogenic-variant-why-germline-testing-matters</link>
<description>Huma Q Rana (Dana-Farber Cancer institute) explains a Journal of the National Cancer Institute study of whether germline pathogenic variants were more frequent in people with sarcoma than in cancer-free controls</description>
<pubDate>Tue, 30 Dec 25 06:52:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>Genetic Testing</category>
</item>
</channel>
</rss>
